Prescient Surgical's novel wound retractor CleanCision is associated with reduced bacterial contamination in colorectal surgery, according to a study in the World Journal of Surgery.
Here are five things to know.
1. Colorectal surgery has high rates of surgical site infection, and according to a Clinical Microbiology and Infection study, up to half of all abdominal incisions may be contaminated during colon surgery.
2. This prospective multicenter pilot study used CleanCision, a wound retractor combining continuous irrigation and barrier protection in 86 patients undergoing elective colorectal resection.
3. CleanCision was associated with a 66 percent reduction in overall bacterial contamination at the protected incision edge compared to the exposed incision edge and a 71 percent reduction in enteric bacterial contamination.
4. There were no adverse effects attributed to CleanCision use.
5. Prescient Surgical received FDA 510(k) approval for CleanCision in 2017.
More articles on gastroenterology:
61% of gastroenterologists to participate in MIPS: 5 things to know about GI payment models
Colorectal SSI rate decreased 61.7% in Hawaii — 4 things to know